Logo

Inovio's Novel HPV Therapy INO-3106 Demonstrates Clinical Effi...

PLYMOUTH MEETING, Pennsylvania, April 3, 2019 /PRNewswire-AsiaNet/ -- -- Clinical Data Presented at Annual Meeting of American Association for Cancer Research Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced its novel therapy INO-3106 against the human papilloma virus type 6 (HPV 6) demonstrated clinica...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660